2- (2- cresyl)- 4H- 1- 3- 2- benzodioxaphosphorin- 2- oxide

Subscribe to Selected New Research on 2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide

6 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: cyclic metabolite of tri-o-cresyl phosphate; synergist for cholinesterase inhibitors

Also Known As:

0-tosylsaligenin phosphate; 2-(o-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide; 2-TSLPH; 2-tolylsaligenin phosphate; 2-tosylsaligenin phosphate; CBDP; SCOTP; o-TSP; saligenin cyclic-3-tolylphosphate; 4H-1,3,2-Benzodioxaphosphorin, 2-(2-methylphenoxy)-, 2-oxide

Bio-Agent Context: Research Results

Organic Chemicals: 40

Organophosphorus Compounds: 126

2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide: 6

Related Diseases

1.	Poisoning 07/11/1979 - "The influence of 2-/o-cresyl/-4 H-1 : 3 : 2-benzodioxa-phosphorin-2-oxide (CBDP) on organophosphate poisoning and its therapy." 01/01/1993 - "This suggests that such CBDP-pretreated animals can be used in investigations that are relevant for prophylaxis and therapy of intoxication with C(+/-)P(+/-)-soman in primates including humans" 07/01/1989 - "The dose-dependent severity of soman intoxication varied widely in rats treated with soman alone but not in CBDP-pretreated rats, and the ED50 for the occurrence of signs of soman intoxication was reduced approximately 7-fold following CBDP (1.0 mg/kg) pretreatment" 07/11/1979 - "The protective index of atropine + HS-3 in sarin poisoning, as in the case of soman poisoning, was much higher in CBDP pretreated than in control animals (20.1 : 13.6), only slightly higher in tabun poisoning (4.3 : 3.4) and in the case of VX poisoning lower in CBDP pretreated than in control animals (32 : 47)" 07/11/1979 - "The protective effect of atropine and the oximes HS-3, HS-6 and HI-6 in soman poisoning was much greater in CBDP pretreated than in control animals" Get all the results and reference details, order at left...
2.	Spasm (Spasms) 06/01/1986 - "Common bile duct pressure (CBDP) did not differ significantly between the SPO spasm group and control patients, but in the fentanyl test the CBDP elevation was significantly higher (p less than 0.01) than in controls (7.7 versus 3.3 mm Hg)" Get all the results and reference details, order at left...
3.	Neoplasms (Cancer) 10/01/2004 - "The inhibitory effect of CBDP, HO-TOTP, and 3-BCP on FAEE synthase and esterase activity was studied using rat hepatic and pancreatic postnuclear (PN) fractions, commercial porcine hepatic CE and pancreatic ChE, and in HepG2 and rat pancreatic tumor (AR42J) cell lines" Get all the results and reference details, order at left...
4.	Cholangitis 02/01/1992 - "On the basis of common bile duct pressure measurement (CBDP) in 18 patients of severe acute cholangitis, plasma endotoxin (ET) was determined by modified synthetic chromogenic limulus amebocyte lysate assay and plasma fibronectin (FN) was detected with Laurell's rocket immunoelectrophoresis" Get all the results and reference details, order at left...
4 Diseases and 6 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Soman
2.	Sarin
3.	Oximes
4.	Fibronectins (Fibronectin)
5.	Fentanyl (Sublimaze)
6.	Atropine (Hyoscyamine)
7.	fatty acyl ethyl ester synthase
8.	3-benzyl-6-chloro-2-pyrone
9.	tri-o-cresyl phosphate (TOTP)
10.	HI 6 (H16)
14 Drugs and Important Bio-Agents and 6 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>